Harmony Biosciences Holdings, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC HRMY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

139,939

Value ($000)

5,237

Weight

0.0%

2021 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,237	0.0%	139,939	12/31/2025
2025 Q3	11/14/2025	1,926	0.0%	69,870	9/30/2025
2025 Q2	8/14/2025	4,144	0.0%	131,124	6/30/2025
2025 Q1	5/19/2025	3,166	0.0%	95,389	3/31/2025
2024 Q4	2/14/2025	2,145	0.0%	62,331	12/31/2024
2024 Q3	11/14/2024	2,466	0.0%	61,653	9/30/2024
2024 Q2	8/14/2024	2,063	0.0%	68,372	6/30/2024
2024 Q1	5/15/2024	1,235	0.0%	36,779	3/31/2024
2023 Q4	2/14/2024	1,188	0.0%	36,779	12/31/2023
2023 Q3	11/13/2023	1,261	0.0%	38,492	9/30/2023
2023 Q2	8/11/2023	412	0.0%	12,619	6/30/2023
2023 Q1	5/15/2023	412	0.0%	12,619	3/31/2023
2022 Q4	2/14/2023	1,714	0.0%	31,100	12/31/2022
2022 Q3	11/14/2022	1,098	0.0%	24,792	9/30/2022
2022 Q2	8/12/2022	858	0.0%	17,583	6/30/2022
2022 Q1	5/16/2022	855	0.0%	17,583	3/31/2022
2021 Q4	2/14/2022	513	0.0%	12,024	12/31/2021